#5. Activating RET mutations in medullary thyroid cancer cells promotes osteoblastic bone metastasis by inhibiting osteoclastogenesis and stimulating osteoblast activity
Rozita Bagheri-Yarmand,
Gabriel M Pagnotti,
Trupti Trivedi,
Leah Guerra,
Joseph L. Kidd,
Jade A. Martinez,
Jian H. Song,
Sua-Hwa Lin,
Theresa A. Guise
Affiliations
Rozita Bagheri-Yarmand
Department of Endocrine Neoplasia and HD, Genitourinary Medical Oncology, Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, USA
Gabriel M Pagnotti
Department of Endocrine Neoplasia and HD, Genitourinary Medical Oncology, Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, USA
Trupti Trivedi
Department of Endocrine Neoplasia and HD, Genitourinary Medical Oncology, Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, USA
Leah Guerra
Department of Endocrine Neoplasia and HD, Genitourinary Medical Oncology, Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, USA
Joseph L. Kidd
Department of Endocrine Neoplasia and HD, Genitourinary Medical Oncology, Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, USA
Jade A. Martinez
Department of Endocrine Neoplasia and HD, Genitourinary Medical Oncology, Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, USA
Jian H. Song
Department of Endocrine Neoplasia and HD, Genitourinary Medical Oncology, Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, USA
Sua-Hwa Lin
Department of Endocrine Neoplasia and HD, Genitourinary Medical Oncology, Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, USA
Theresa A. Guise
Department of Endocrine Neoplasia and HD, Genitourinary Medical Oncology, Translational Molecular Pathology, the University of Texas MD Anderson Cancer Center, USA
